3 latest FDA approvals

Here are the three latest drugs or medical devices approved by the FDA since June 29:

1. Aristada Initio is an alternative, extended-release version of Aristada, a long-acting injectable antipsychotic used to treat adults with schizophrenia. 

2. The Zephyr Endobronchial Valve is implanted into a patient's lung to treat breathing issues associated with severe emphysema.

3. Xeomin is intended to treat chronic sialorrhea, or excessive drooling, in adults.

More articles on supply chain:
10 most-read supply chain stories in June
CMS grants Oklahoma's amendment to negotiate value-based rebates with drugmakers
FDA releases 2nd draft of its software pre-certification program

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers